Robotic Surgery Offers New Hope for Pancreatic Cancer Treatment
Robotic Surgery Hope for Pancreatic Cancer

Pancreatic cancer surgery is notoriously complex, but robotic hands offer some hope for precision and improved outcomes. Pancreatic cancer has a 98% mortality rate and is often diagnosed late due to its hidden anatomical position, earning it the nickname 'Mount Everest of general surgery'. The pancreas is surrounded by critical organs and major blood vessels, making surgeries like the Whipple procedure extremely complex and high-risk. Robotic systems like the da Vinci Surgical System provide 3D visualisation and enhanced precision, improving surgical navigation but not eliminating reconstruction complexities. Only 15% of cases are detected early, with 40% requiring chemotherapy before surgery due to tumour attachment to surrounding structures. Post-surgery complications from reconstructing the gastrointestinal tract significantly reduce survival rates, even after successful tumour removal.

Key Statistics

  • 98%: Pancreatic cancer mortality rate
  • Not more than five years: Five-year survival rate for pancreatic cancer
  • 22,980 cases: Annual pancreatic cancer cases in India
  • 15%: Early-stage diagnosis rate

Processed with AI. Reviewed by DH Digital Team.

Pickt after-article banner — collaborative shopping lists app with family illustration